Tide Has Turned on P&G's Sales Course, Shares Pricey
Wide-moat Procter & Gamble chalked up another quarter of strong sales and profit gains.
Wide-moat Procter & Gamble chalked up another quarter of strong sales and profit gains.
Even in the face of more robust comparisons, wide-moat Procter & Gamble (PG) chalked up another quarter of strong sales and profit gains, evidencing the prudence of its current strategic course (anchored in driving productivity savings to fuel continued investments behind consumer-valued innovation after pruning its mix over the past several years). In the quarter, organic sales popped 7% on a 290-basis-point and 260-basis-point expansion in adjusted gross and operating margins, respectively, to 51.3% and 24.3%. Not only did the firm’s top-line bump come on top of a 4% uptick in the year-ago period, but growth was fairly balanced between price (up 1%), mix (a 2% benefit), and volumes (4% higher).
As a result of the solid start to the year, management raised its sales and earnings guidance modestly, which now sits at 3%-5% growth (from 3%-4%) and 5%-10% (from 4%-9%) growth, respectively. While our prior 3% and 7% marks continue to align with the revised outlook, we will likely edge up our $103 per share valuation by a low-single-digit percentage to account for the continued outsize performance and the time value of money. However, we don’t anticipate altering our longer-term forecast of 3%-4% annual sales growth and more than 24% operating margins by fiscal 2029, up from an average of 21.6% over the past three years. Shares traded up by around a 3% clip following the print, and as such, sit at a lofty 15%-20% premium to our assessment of P&G’s intrinsic value.
We’ve long been in the camp that P&G was poised to boast more robust sales performance, but we aren’t blind to the fact that it will soon lap tougher comparisons (that inflate throughout the rest of the year) and persistent competitive headwinds (which could include increased promotional activity particularly if the raw material inflation remains tempered, inciting competitors to reduce prices to eat into P&G’s market share) that could derail its trajectory.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days. |
Erin Lash does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.